Dermata, GH Research top healthcare gainers; BridgeBio, Cidara among losers

Mar. 24, 2023 10:01 AM ETHRTX, MYMD, CDTX, COSM, BBIO, IONM, VACC, GHRS, DRMA, TCBPBy: Ravikash, SA News Editor2 Comments

Gainers: Dermata Therapeutics (DRMA) +40%. GH Research (GHRS) +27%. Vaccitech (VACC) +25%. Cosmos Health (COSM) +10%. Assure (IONM) +6%.
Losers: BridgeBio Pharma (BBIO) -9%. Cidara Therapeutics (CDTX) -9%. MyMD Pharmaceuticals (MYMD) -9%. TC Biopharm (TCBP) -8%. Heron Therapeutics (HRTX) -6%.
S&P 500 Healthcare sector is currently down -0.45% to 1,458.79. Health Care Equipment & Services is down -0.08% and Pharmaceuticals, Biotechnology & Life Sciences are down -0.52%.